Is Aspire Biopharma Holdings, Inc. (ASBP) a Buy, Sell, or Hold?
NASDAQ : ASBP
Aspire Biopharma Holdings, Inc.
$6.24 USD
-$0.04 (-0.64%)
- Volume
- 25.45K
- Average Volume
- 13.06M
- Market Capitalization
- $719.92K
- P/E Ratio
- -0.74
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $35.00
- Year Low
- $0.11
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.26
Company Overview
NASDAQ
Kraig T. Higginson
Biotechnology
Healthcare
ASBP
2
US
USD
Liquidity Metrics
0.39
2.26
2.14
1.86
0.00
Sales & Valuation
$6202
20.83
2.41
-0.12
-4.15
Profitability
-$16.38
-$24.48M
-34039.68%
-34039.68%
199.43%
-165.27%
P/E Metrics
-0.74
-0.01
-0.01
Analyst Price Target & Rating
1/5
0 Analysts
%
Poll Results
About Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) Stock
Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction dru ... gs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.
2026-06-24 08:30:00
The brand expands nationwide distribution on Amazon, delivering a waterless, rapid-dissolve 50 mg caffeine powder built for active, on-the-go lifestyles. ESTERO, FL / ACCESS Newswire / June 24, 2026 / Aspire Biopharma Holdings, Inc.'s (Nasdaq:ASBP) ("Aspire" or the "Company") wholly owned subsidiary Buzz Bomb Caffeine Company LC today announced the nationwide Amazon launch of its innovative BUZZ BOMB™ 50mg caffeine stick packs.
Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th
2026-06-17 10:57:00
ESTERO, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- Aspire Biopharma Holdings, Inc.'s (Nasdaq: ASBP) (“Aspire” or the “Company”), today announced that it will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on June 25th, 2026.
Aspire Biopharma Stock Is Sliding Today: What's Going On?
2026-06-12 10:11:42
Aspire Biopharma Holdings Inc. (NASDAQ:ASBP) shares initially surged on Friday but have since reversed. Here's what you need to know.
2026-06-12 08:30:00
Adds an established global brand with scale in large and growing markets driven by trends in vehicle and mobility control systems Acquisition significantly accelerates Aspire's revenue, earnings growth and cash flow profile Strategically diversifies Aspire's revenue streams Opportunity to drive significant shareholder value creation and enhance long-term capital allocation optionality Company does not anticipate procuring new equity financing to consummate the transaction ESTERO, FL / ACCESS Newswire / June 12, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), today announced the signing of a definitive Share Purchase Agreement ("SPA") for the acquisition of 100% of Dura Driver Control Systems ("DCS"), a premier designer and manufacturer of automotive driver control systems with expanding industrial applications. The proposed acquisition represents a transformative milestone for Aspire, positioning the Company to rapidly evolve into a diversified, high-revenue enterprise.
Aspire Biopharma Issues Shareholder Letter
2026-05-28 08:30:00
ESTERO, FL / ACCESS Newswire / May 28, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today issued the following letter to shareholders from Chief Executive Officer Kraig Higginson. Dear Fellow Shareholders, 2026 is shaping up to be a defining year for Aspire Biopharma Holdings.
2026-05-27 08:30:00
ESTERO, FL / ACCESS Newswire / May 27, 2026 / Aspire Biopharma Holdings, Inc.'s (Nasdaq:ASBP) ("Aspire" or the "Company") wholly owned subsidiary Buzz Bomb Caffeine Company LC is proud to announce a strategic partnership with EoS Fitness, the High Value. Low Price.
Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio
2026-05-07 11:00:00
ESTERO, FL / ACCESS Newswire / May 7, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today announced that it will effect a one-for-thirty (1:30) reverse stock split (the "reverse split") of its common stock, par value $0.0001 per share (the "Common Stock"), that will become effective on May 11, 2026, at 12:01 AM Eastern Time, before the opening of trading on The Nasdaq Capital Market ("Nasdaq"). Aspire has requested that its Common Stock begin trading on May 11, 2026, on a post-reverse split basis on the Nasdaq under the existing symbol "ASBP".
Aspire Biopharma Announces $5.0 Million Share Repurchase Program
2026-04-27 08:30:00
ESTERO, FL / ACCESS Newswire / April 27, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced that its Board of Directors (the "Board") has authorized the repurchase of up to $5.0 million of the Company's common stock. The authorization reflects the Board's confidence in the Company's balance sheet strength, the value of its drug development pipeline and supplement business, and the potential value creation from the recently announced Binding Letter of Intent (LOI) to acquire Dura Driver Control Systems (DCS).
Frequently Asked Questions
-
What is the current Aspire Biopharma Holdings, Inc. (ASBP) stock price?
-
Aspire Biopharma Holdings, Inc.(NASDAQ:ASBP) stock price is $6.24 in the last trading session. During the trading session, ASBP stock reached the peak price of $35 while $0.11 was the lowest point it dropped to. The percentage change in ASBP stock occurred in the recent session was --0.64% while the dollar amount for the price change in ASBP stock was -$0.04.
-
ASBP's industry and sector of operation?
-
The NASDAQ listed ASBP is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ASBP?
-
Stephen E. Quesenberry | General Counsel & Corporate Secretary
Kraig T. Higginson | Interim Chief Executive Officer, President & Executive Chairman of the Board
Ernest J. Scheidemann Jr. | Chief Financial Officer
|
| -
How many employees does ASBP have?
-
Number of ASBP employees currently stands at 2. ASBP operates from 23150 Fashion Drive, Estero, FL 33928, US.
-
Link for ASBP official website?
-
Official Website of ASBP is: https://aspirebiolabs.com
-
How do I contact ASBP?
-
ASBP could be contacted at phone #415 592 7399 and can also be accessed through its website. ASBP operates from 23150 Fashion Drive, Estero, FL 33928, US.
-
How many shares of ASBP are traded daily?
-
The average number of ASBP shares traded daily for last 3 months was 13.06M.
-
What is the market cap of ASBP currently?
-
The market value of ASBP currently stands at $719.92K with its latest stock price at $6.24